Want to join the conversation?
In the near term, $VRTX expects cash flow from product revenues to increase due to sales of cystic fibrosis drug Orkambi in the U.S. after receipt of FDA approval in July. $VRTX does not expect significant product revenue from Orkambi in 2015 from ex-U.S. markets.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!